News-Medical announces partnership with World Orphan Drug Congress

Engage with over 2000 attendees at the World Orphan Drug Congress Europe, focusing on gene therapy and strategies for rare disease treatment advancements.

UK biotech brings in $226M Series C

Apol­lo Ther­a­peu­tics is reel­ing in a $226.5 mil­lion Se­ries C round, the biotech said Wednes­day. The fi­nanc­ing is two-pronged: It aims to ad­vance Apol­lo’s clin­i­cal

Read More »